simultaneous inhibition of mtor-containing complex 1 (mtorc1) and mnk induces apoptosis of cutaneous t-cell lymphoma (ctcl) cells同时抑制mtor-containing复杂1(mtorc1)和mnk皮肤t细胞淋巴瘤(ctcl)细胞的凋亡.pdfVIP

simultaneous inhibition of mtor-containing complex 1 (mtorc1) and mnk induces apoptosis of cutaneous t-cell lymphoma (ctcl) cells同时抑制mtor-containing复杂1(mtorc1)和mnk皮肤t细胞淋巴瘤(ctcl)细胞的凋亡.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
simultaneous inhibition of mtor-containing complex 1 (mtorc1) and mnk induces apoptosis of cutaneous t-cell lymphoma (ctcl) cells同时抑制mtor-containing复杂1(mtorc1)和mnk皮肤t细胞淋巴瘤(ctcl)细胞的凋亡

Simultaneous Inhibition of mTOR-Containing Complex 1 (mTORC1) and MNK Induces Apoptosis of Cutaneous T- Cell Lymphoma (CTCL) Cells 1 1 2 2 3 1 Michal Marzec , Xiaobin Liu , Maria Wysocka , Alain H. Rook , Niels Odum , Mariusz A. Wasik * 1 Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, 2 Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, 3 Institute of Molecular Biology, University of Copenhagen, Copenhagen, Denmark Abstract Background: mTOR kinase forms the mTORC1 complex by associating with raptor and other proteins and affects a number of key cell functions. mTORC1 activates p70S6kinase 1 (p70S6K1) and inhibits 4E-binding protein 1 (4E-BP1). In turn, p70S6K1 phosphorylates a S6 protein of the 40S ribosomal subunit (S6rp) and 4E-BP1, with the latter negatively regulating eukaryotic initiation factor 4E (eIF-4E). MNK1 and MNK2 kinases phosphorylate and augment activity of eIF4E. Rapamycin and its analogs are highly specific, potent, and relatively non-toxic inhibitors of mTORC1. Although mTORC1 activation is present in many types of malignancies, rapamycin-type inhibitors shows relatively limited clinical efficacy as single agents. Initially usually indolent, CTCL displays a tendency to progress to the aggressive forms with limited response to therapy and poor prognosis. Our previous study (M. Marzec et al. 2008) has demonstrated that CTCL cells display mTORC1 activation and short-term treatment of CTCL-derived cells with rapamycin suppressed their proliferation and had little effect on the cell survival. Methods: Cells derived from CTCL were treated with mTORC1 inhibitor rapamycin and MNK inhi

您可能关注的文档

文档评论(0)

xyz118 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档